Even if they’re not acquired, these small companies are developing promising obesity and diabetes treatments.
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.
Read Next
- Mortgage rates spike after jobs report
- 8 subtle phrases that indicate a high level of intelligence, according to psychology
- Ghostly Pumpkin Spice Mousse Cups
- US30 ripe for a steep pullback? :: InvestMacro
- GM halts production at two major U.S. plants due to Hurricane Helene
- Want to solve a complex problem? Applied math can help :: InvestMacro
- RBI appoints Aviral Jain as Executive Director, BFSI News, ET BFSI
